Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infection.
Castro
Kenneth G
KG
Jereb
John A
JA
Koppaka
Venkatarama Rao
VR
Cohn
David L
DL
D016907:Adverse Drug Reaction Reporting Systems; D000995:Antitubercular Agents / Q000009:adverse effects*; D002487:Centers for Disease Control and Prevention, U.S.; D004359:Drug Therapy, Combination; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced* / Q000453:epidemiology; D011718:Pyrazinamide / Q000009:adverse effects*; D012293:Rifampin / Q000009:adverse effects*; D014376:Tuberculosis / Q000188:drug therapy*; D014481:United States / Q000453:epidemiology
D000995:Antitubercular Agents; D011718:Pyrazinamide; D012293:Rifampin